Hyderabad: Bharat Biotech International has announced the launch of Nucelion Therapeutics Pvt Ltd, Hyderabad-based Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and gene therapies. The wholly owned subsidiary of Bharat Biotech is part the company's strategic expansion into the fast-growing field of next-generation Cell and Gene Therapy CRDMO. The CRDMO aims to support global life science innovators with scalable process development and manufacturing solutions for advanced therapies, indicated for cancers, autoimmune disorders, and rare genetic disorders. Spread across a 30,000 square foot purpose-built facility in Genome Valley, Nucelion has commissioned a GMP facility capable of developing and manufacturing plasmids, viral and non-viral vec

See Full Page